BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250515T120000
DTEND;TZID=America/New_York:20250515T130000
DTSTAMP:20260409T113059
CREATED:20250513T141015Z
LAST-MODIFIED:20250513T141015Z
UID:10001553-1747310400-1747314000@www.med.unc.edu
SUMMARY:DOM Grand Rounds- Dr. Stergios Moschos & Dr. David Ollila presents: " Do NOT Throw the Baby Out with the Bath Water"
DESCRIPTION:Stergios Moschos\, MD\, has a research focus on identifying molecules that are important for melanoma development and progression\, identifying mechanisms of action of FDA-approved and investigational agents in melanoma. \nFor example\, he identified that Ubc9\, the single SUMO E2 conjugating enzyme is highly expressed in melanoma-infiltrated lymph nodes and that targeting Ubc9 in melanoma cell lines enhances the cytotoxic effect of chemotherapeutic agents. Furthermore\, he studied the mechanism of action of high-dose interferon as part of a neoadjuvant trial in patients with stage III melanoma. \n  \n  \n  \n  \n  \n  \n \nDavid Ollila\, MD\, is a general surgical oncologist with broad training in all aspects of surgical oncology. His special areas of interest are in melanoma\, breast cancer\, and the surgical management of endocrine disorders\, with a focus on providing a translational step for basic scientists between the laboratory and the clinic. During his training at John Wayne Cancer Institute\, Ollila became very familiar with the polyvalent melanoma vaccines being studied there. At UNC\, he has initiated two vaccine clinical trials that will lead to further immunotherapy research and clinical applications in this area. Ollila is planning collaborative work on melanoma sentinel nodes in an epidemiology study being run by the UNC School of Public Health. \nOllila’s breast cancer research interests include work derived from his expertise in sentinel node biopsy\, a technique for identifying the lymph node most likely to contain cancer metastasis. He was one of the first to examine the use of sentinel lymph node biopsy as a method to improve the ability to determine tumor extent and minimize surgery in women undergoing neoadjuvant\, or preoperative\, chemotherapy. He has also developed a method using a new technique for identifying cancer\, positron emission tomography (PET) to help guide surgery after chemotherapy. This method is being tested in an ongoing clinical trial.
URL:https://www.med.unc.edu/medicine/event/dom-grand-rounds-dr-stergios-moschos-dr-david-ollila-presents-do-not-throw-the-baby-out-with-the-bath-water/
LOCATION:Room 4008 Old Clinic Auditorium\, Chapel Hill\, NC\, United States
CATEGORIES:Medicine Grand Rounds
END:VEVENT
END:VCALENDAR